Types of Hair Loss Addressed Minoxidils FDA approval specifically covers androgenetic alopecia (pattern hair loss) in both men and women
Singh S, Bedoy A, Muftuoglu M, Li L, Okeleji O, Dipmoy N, Ostermann L, Veletic I, Pacheco C, Basyal M, Kim T, Garland KM, Angel M, Luther S, Rohde C, Andreeff M , Anand V
Limited Scope of FDA Approval The most significant limitation is the narrow approved indication: FDA approval restricted exclusively to acquired, generalized hypoactive sexual desire disorder in premenopausal women No approved indication for men despite Phase 2 evidence of erectile dysfunction improvement No approval for postmenopausal women No approval for other forms of sexual dysfunction beyond HSDD All use outside this single indication represents off-label prescribing based on limited clinical trial data and physician clinical experience
GHK-Cu is often discussed for its ability to bind copper and deliver it in a form that the skin can recognize